“Performance and Clinical Decision-Making Using the Prognostic 40-Gene Expression Profile (40-GEP) Test in 1,018 Patients With High-Risk Cutaneous Squamous Cell Carcinoma (SCC)”. SKIN The Journal of Cutaneous Medicine 6, no. 6 (November 16, 2022): s96. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/1855.